Canonical: https://ownershiptrace.com/13f/companies/1120

# Who owns Indivior Pharmaceuticals, Inc. (INDV)? Elite investor 13F holders

4 tracked elite investors reported holding Indivior Pharmaceuticals, Inc as of 2026-06-30, including Oaktree Capital Management, D.E. Shaw, Gotham Asset Management, Bridgewater Associates. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.

4 tracked investors currently reported holding · Latest report period: 2026-06-30 · Health Care · Pharmaceuticals, Biotechnology & Life Sciences

Indivior Pharmaceuticals, Inc., together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and related disorders in the United States, Europe, Canada, Australia, and internationally. It develops medicines to treat substance use disorders. The company's core marketed products include SUBLOCADE…

## Reported holders and securities, including exits (up to 20)

| Investor | Security | Instrument | Report period | Filed | Value | Quantity | Units | Change | Source |
|  --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| [Oaktree Capital Management](https://ownershiptrace.com/13f/investors/44) | INDIVIOR PHARMACEUTICALS INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 251399508.00 USD | 6127212.000000 | Shares | buy | [Original filing](https://www.sec.gov/Archives/edgar/data/949509/0000949509-26-000005-index.html) |
| [Rubric Capital](https://ownershiptrace.com/13f/investors/120) | INDIVIOR PHARMACEUTICALS INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 0.00 USD | 0.000000 | Shares | exited | [Original filing](https://www.sec.gov/Archives/edgar/data/1687509/0001104659-26-097098-index.html) |
| [D.E. Shaw](https://ownershiptrace.com/13f/investors/98) | INDIVIOR PHARMACEUTICALS INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 9684475.00 USD | 236034.000000 | Shares | add | [Original filing](https://www.sec.gov/Archives/edgar/data/1009207/0001104659-26-097217-index.html) |
| [Gotham Asset Management](https://ownershiptrace.com/13f/investors/94672) | INDIVIOR PLC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 0.00 USD | 0.000000 | Shares | exited | [Original filing](https://www.sec.gov/Archives/edgar/data/1510387/0001398344-26-014644-index.html) |
| [Gotham Asset Management](https://ownershiptrace.com/13f/investors/94672) | INDIVIOR PHARMACEUTICALS INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 3891696.00 USD | 94850.000000 | Shares | buy | [Original filing](https://www.sec.gov/Archives/edgar/data/1510387/0001398344-26-014644-index.html) |
| [Bridgewater Associates](https://ownershiptrace.com/13f/investors/8) | INDIVIOR PHARMACEUTICALS INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 2797466.00 USD | 68181.000000 | Shares | add | [Original filing](https://www.sec.gov/Archives/edgar/data/1350694/0001350694-26-000003-index.html) |

Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.

This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.

[How to read the data](https://ownershiptrace.com/docs#reading-the-data) · [Disclaimer](https://ownershiptrace.com/disclaimer)